The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the ...

GRAIL (GRAL) announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer, or ...

PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

A mother who was diagnosed with stage 4 lung cancer at just 34 years old has outlined five symptoms that she ignored and ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

Last November, Pyxis revealed it would continue to focus on PYX-201 as its lead asset, while pausing other early-stage ...

Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha ...

Researchers have discovered a significant association between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC). NPC is a cancer notably prevalent in southern China, where ...

Dr. Jianjun ZOU, General Manager and CEO of Junshi Biosciences, said, “The approval of toripalimab by MHRA marks another significant milestone for toripalimab in Europe, not onl ...

These early-onset cancers, which impact patients between the ages of 18 and 49, are on the rise in a wide swath of cancers.